Tag: Bristol-Myers Squibb

April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
April 4, 2019

SELLAS Life Sciences Group and Cancer Center to Study Galinpepimut-S in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma

SELLAS Life Sciences Group (NASDAQ:SLS) has announced it has signed an agreement with Memorial Sloan Kettering Cancer Center for an...
February 26, 2019

Senate Finance Committee Blasts Pharma CEOs on Drug Prices

This was the largest panel of pharmaceutical executives "in decades" to appear before a congressional committee.
February 3, 2019

Checkpoint Inhibitors Driving the Immunotherapy Market

The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
December 24, 2018

Pharma Outlook 2019: Drug Pricing Dialogue Continues

During this challenging time in healthcare news, our pharma outlook aims to help investors steer through the industry.
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?